Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
January 4th, 2023
Sports Law In 2023 – Key Issues To Watch In North America
Sports Group Partner Christopher R. Chase speaks with LawInSport on the sports law issues to watch out for in 2023. Christopher contributes his thoughts on student-athlete name, image, and likeness laws, rules and contracts:
“The continued refinement of student-athlete name, image, and likeness laws, rules, and even contracts will be worth watching in 2023. With over a year of deals in the marketplace, brands can assess the value of student-athletes as ambassadors and endorsers – and student-athletes are able to better understand an entirely new process (e.g., signing agreements, dealing with scheduling issues, and understanding what marketers want posted).
Also, the on-going investigation by the U.S. Department of Justice into the PGA Tour for potential antitrust violations will be interesting, as it is not often that the federal government gets involved in the operations of a major sports league/competition (usually that only happens after a scandal…).”
See the full article here. (Behind paywall).
Other Quoted
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
What Cannes Lions Can Teach Us About Advertising’s Most Important Customer
Cannes Lions brought important conversations to the stage about advertising’s most important stakeholder: the public. Read more.
July 2 2026
